Quaker Houghton (KWR) Releases Q1 2026 Earnings: Revenue Beats, EPS Miss

Select Medical Holdings Corporation (SEM) reported first-quarter 2026 revenue of $1.42 billion, up 5.1% year-over-year. Diluted earnings per share came in at $0.35, a decline of 20.5% from the prior year.

Gross profit: $175.47 million (down 2.8% year-over-year).

Operating profit: $98.42 million (down 12.7% year-over-year).

Net income attributable to common shareholders: $44.00 million (down 22.4% year-over-year).

Cost of sales: $1.25 billion (up 6.3% year-over-year).

Diluted EPS: $0.35 (down 20.5% year-over-year).

Margins tightened during the quarter, with a gross margin of about 12.3%, an operating margin around 6.9%, and a net margin near 3.1%. The faster rise in cost of sales relative to revenue contributed to pressure on operating profit and net income.

Cash from operating activities: $37.86 million (down about 1,195% year-over-year).

Capital spending (purchases of property, plant and equipment): $58.90 million (up 12.5% year-over-year).

Cash and cash equivalents: $25.68 million (down 51.7% year-over-year).

Total liabilities: $3.92 billion (up 7.3% year-over-year).

The quarter missed analyst expectations on both revenue and EPS: revenue came in slightly below the estimate of $1.43 billion, and adjusted EPS trailed the estimate of $0.46. Overall, Select Medical (SEM) delivered revenue growth but faced margin and cash-flow headwinds that pressured profitability this quarter.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

EARLY ACCESS

Receive SEM Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Select Medical Holdings Corporation Hedge Fund Activity

We have seen 137 institutional investors add shares of Select Medical Holdings Corporation stock to their portfolio, and 140 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HSBC HOLDINGS PLC added 2,215,832 shares (+7554.6%) to their portfolio in Q1 2026, for an estimated $36,095,903
PRINCIPAL FINANCIAL GROUP INC removed 1,907,815 shares (-78.4%) from their portfolio in Q4 2025, for an estimated $28,331,052
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,783,236 shares (-62.4%) from their portfolio in Q4 2025, for an estimated $26,481,054
ALPINE ASSOCIATES MANAGEMENT INC. added 1,176,700 shares (+inf%) to their portfolio in Q1 2026, for an estimated $19,168,443
MILLENNIUM MANAGEMENT LLC removed 1,042,186 shares (-65.5%) from their portfolio in Q4 2025, for an estimated $15,476,462
WESTERN STANDARD LLC added 1,008,664 shares (+95.6%) to their portfolio in Q4 2025, for an estimated $14,978,660
EVERSEPT PARTNERS, LP added 906,100 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,455,585

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

Select Medical Holdings Corporation Government Contracts

We have seen $161,381 of award payments to $SEM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

PROSTHETIC LIMB: $53,422
AVIATION SECURITY OFFICERS (ASOS) FIT-FOR-DUTY MEDICAL EXAMS, DRUG SCREENING AND TB SKIN TESTING FOR OKLAHO...: $20,500
PROSTHETIC LIMB: $19,427
EXPRESS REPORT: FIRST LEG RIGHT BK: $12,493
EXPRESS REPORT: REPAIR AK PROSTHESIS: $12,165

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.